{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T18:26:10Z","timestamp":1792175170116,"version":"4.4.0"},"reference-count":193,"publisher":"Impact Journals, LLC","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2026,1,3]]},"DOI":"10.18632\/oncotarget.28824","type":"journal-article","created":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T15:00:26Z","timestamp":1767711626000},"page":"1-29","source":"Crossref","is-referenced-by-count":5,"title":["COVID vaccination and post-infection cancer signals: Evaluating patterns and potential biological mechanisms"],"prefix":"10.18632","volume":"17","author":[{"given":"Charlotte","family":"Kuperwasser","sequence":"first","affiliation":[{"name":"Department of Developmental, Molecular and Chemical Biology, Tufts University School of Medicine, Boston, MA 02111, USA"},{"name":"Laboratory for the Convergence of Biomedical, Physical, and Engineering Sciences, Tufts University School of Medicine, Boston, MA 02111, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wafik S.","family":"El-Deiry","sequence":"additional","affiliation":[{"name":"Laboratory of Translational Oncology and Experimental Cancer Therapeutics, Department of Pathology and Laboratory Medicine, The Warren Alpert Medical School of Brown University, Providence, RI 029121, USA"},{"name":"Hematology-Oncology Division, Department of Medicine, Brown University Health and The Warren Alpert Medical School of Brown University, Providence, RI 029121, USA"},{"name":"Legorreta Cancer Center at Brown University, The Warren Alpert Medical School of Brown University, Providence, RI 029121, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7892","published-online":{"date-parts":[[2026,1,3]]},"reference":[{"key":"1","doi-asserted-by":"publisher","first-page":"424","DOI":"10.3390\/vaccines13040424","article-title":"Beyond the Pandemic Era: Recent Advances and Efficacy of SARS-CoV-2 Vaccines Against Emerging Variants of Concern","volume":"1","author":"Pathak","year":"2025","journal-title":"Vaccines (Basel)"},{"key":"2","doi-asserted-by":"publisher","first-page":"102527","DOI":"10.1016\/j.omtn.2025.102527","article-title":"Looking beyond the origin of SARS-CoV-2: Significant strategic aspects during the five-year journey of COVID-19 vaccine development","volume":"3","author":"Wen","year":"2025","journal-title":"Mol Ther Nucleic Acids"},{"key":"3","doi-asserted-by":"publisher","first-page":"1003203","DOI":"10.37349\/ei.2025.1003203","article-title":"Advancements in viral vaccine development: from traditional to modern approaches","volume":"5","author":"Mishra","year":"2025","journal-title":"Explor Immunol"},{"key":"4","doi-asserted-by":"publisher","first-page":"989","DOI":"10.3390\/vaccines13090989","article-title":"Advances in Biotechnology and the Development of Novel Human Vaccines","volume":"1","author":"Michos","year":"2025","journal-title":"Vaccines (Basel)"},{"key":"5","doi-asserted-by":"publisher","first-page":"1308768","DOI":"10.3389\/fphar.2024.1308768","article-title":"An overview and single-arm meta-analysis of immune-mediated adverse events following COVID-19 vaccination","volume":"1","author":"Li","year":"2024","journal-title":"Front Pharmacol"},{"key":"6","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1038\/s41541-024-00893-1","article-title":"Myocarditis associated with COVID-19 vaccination","volume":"9","author":"Cavaleri","year":"2024","journal-title":"NPJ Vaccines"},{"key":"7","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1186\/s12883-023-03486-y","article-title":"Neuromuscular diseases associated with COVID-19 vaccines: a systematic review and pooled analysis of 258 patients","volume":"2","author":"Rastad","year":"2023","journal-title":"BMC Neurol"},{"key":"8","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1186\/s40364-025-00831-w","article-title":"1-year risks of cancers associated with COVID-19 vaccination: a large population-based cohort study in South Korea","volume":"1","author":"Chun","year":"2025","journal-title":"Biomark Res"},{"key":"9","doi-asserted-by":"publisher","first-page":"1001314","DOI":"10.37349\/emed.2025.1001314","article-title":"The viral oncogenesis of COVID-19 and its impact on cancer progression, long-term risks, treatment complexities, and research strategies","volume":"6","author":"Al-Ewaidat","year":"2025","journal-title":"Explor Med"},{"key":"10","doi-asserted-by":"publisher","first-page":"e10593","DOI":"10.34172\/npj.2023.10593","article-title":"Cancer recurrence or aggravation following COVID-19 vaccination","volume":"1","author":"Masomi","year":"2023","journal-title":"J Nephropharmacol"},{"key":"11","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1038\/s41392-024-02002-z","article-title":"Progress and prospects of mRNA-based drugs in pre-clinical and clinical applications","volume":"9","author":"You","year":"2024","journal-title":"Signal Transduct Target Ther"},{"key":"12","unstructured":"Comirnaty, t. P.-B. C.-m. v. https:\/\/www.fda.gov\/media\/151707\/download."},{"key":"13","unstructured":"Spikevax, t. M. C.-m. v. https:\/\/www.fda.gov\/media\/155675\/download."},{"key":"14","unstructured":"Mnexspike t. M. C.-l. d. m. v. https:\/\/www.fda.gov\/files\/vaccines%2C%20blood%20%26%20biologics\/published\/Package-Insert-MNEXSPIKE.pdf."},{"key":"15","unstructured":"Nuvaxovid t. N. C.-p.-b. v. https:\/\/www.fda.gov\/files\/vaccines%2C%20blood%20%26%20biologics\/published\/Package-Insert-and-Patient-Package-Insert-NUVAXOVID.pdf."},{"key":"16","doi-asserted-by":"publisher","first-page":"e583","DOI":"10.1016\/S2468-2667(24)00156-7","article-title":"Differences in cancer rates among adults born between 1920 and 1990 in the USA: an analysis of population-based cancer registry data","volume":"9","author":"Jemal","year":"2024","journal-title":"Lancet Public Health"},{"key":"17","doi-asserted-by":"publisher","first-page":"e2328171","DOI":"10.1001\/jamanetworkopen.2023.28171","article-title":"Patterns in Cancer Incidence Among People Younger Than 50 Years in the US, 2010 to 2019","volume":"6","author":"Chong","year":"2023","journal-title":"JAMA Netw Open"},{"key":"18","doi-asserted-by":"publisher","first-page":"10","DOI":"10.3322\/caac.21871","article-title":"Cancer statistics, 2025","volume":"7","author":"Jemal","year":"2025","journal-title":"CA Cancer J Clin"},{"key":"19","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1038\/s41586-025-09655-y","article-title":"SARS-CoV-2 mRNA vaccines sensitize tumours to immune checkpoint blockade","volume":"64","author":"Weidert","year":"2025","journal-title":"Nature"},{"key":"20","doi-asserted-by":"publisher","first-page":"690","DOI":"10.17179\/excli2025-8400","article-title":"COVID-19 vaccination, all-cause mortality, and hospitalization for cancer: 30-month cohort study in an Italian province","volume":"2","author":"Manzoli","year":"2025","journal-title":"EXCLI J"},{"key":"21","doi-asserted-by":"publisher","first-page":"e37612","DOI":"10.7759\/cureus.37612","article-title":"Development of High-Grade Sarcoma After Second Dose of Moderna Vaccine","volume":"1","author":"Bae","year":"2023","journal-title":"Cureus"},{"key":"22","doi-asserted-by":"publisher","first-page":"2775","DOI":"10.1016\/j.radcr.2022.05.035","article-title":"COVID-19 vaccine-associated ganulomatous mass mimicking a sarcoma: a case report","volume":"1","author":"Jose","year":"2022","journal-title":"Radiol Case Rep"},{"key":"23","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.3390\/vaccines12101168","article-title":"Kaposi Sarcoma as a Possible Cutaneous Adverse Effect of ChAdOx1 nCov-19 Vaccine: A Case Report","volume":"1","author":"Yang","year":"2024","journal-title":"Vaccines (Basel)"},{"key":"24","doi-asserted-by":"publisher","first-page":"101986","DOI":"10.1016\/j.ajoc.2023.101986","article-title":"Unilateral conjunctival Classic Kaposi Sarcoma following a COVID 19 booster","volume":"3","author":"Honkanen","year":"2023","journal-title":"Am J Ophthalmol Case Rep"},{"key":"25","doi-asserted-by":"publisher","first-page":"e53925","DOI":"10.7759\/cureus.53925","article-title":"Sporadic Kaposi Sarcoma Following a COVID-19 Vaccine: Mere Coincidence or Something More?","volume":"1","author":"Garc\u00eda Silva","year":"2024","journal-title":"Cureus"},{"key":"26","doi-asserted-by":"publisher","first-page":"157","DOI":"10.3390\/medicina59010157","article-title":"Non-Hodgkin Lymphoma Developed Shortly after mRNA COVID-19 Vaccination: Report of a Case and Review of the Literature","volume":"5","author":"Citterio","year":"2023","journal-title":"Medicina (Kaunas)"},{"key":"27","doi-asserted-by":"publisher","first-page":"1325478","DOI":"10.3389\/fmed.2024.1325478","article-title":"Rare COVID-19 vaccine side effects got lost in the shuffle. Primary cutaneous lymphomas following COVID-19 vaccination: a systematic review","volume":"1","author":"Soko\u0142owska-Wojdy\u0142o","year":"2024","journal-title":"Front Med (Lausanne)"},{"key":"28","doi-asserted-by":"publisher","first-page":"963393","DOI":"10.3389\/fmed.2022.963393","article-title":"Rapid progression of marginal zone B-cell lymphoma after COVID-19 vaccination (BNT162b2): A case report","volume":"9","author":"Tanaka","year":"2022","journal-title":"Front Med (Lausanne)"},{"key":"29","doi-asserted-by":"publisher","first-page":"e0400","DOI":"10.1590\/0037-8682-0400-2022","article-title":"Glioblastoma misdiagnosed as acute disseminated encephalomyelitis following coronavirus disease vaccination","volume":"5","author":"Tasdemir","year":"2022","journal-title":"Rev Soc Bras Med Trop"},{"key":"30","doi-asserted-by":"publisher","first-page":"e61780","DOI":"10.7759\/cureus.61780","article-title":"Types and Rates of COVID-19 Vaccination in Patients With Newly Diagnosed Microsatellite Stable and Instable Non-Metastatic Colon Cancer","volume":"1","author":"Utkan","year":"2024","journal-title":"Cureus"},{"key":"31","doi-asserted-by":"publisher","first-page":"402","DOI":"10.5946\/ce.2023.268","article-title":"Polyposis of gastrointestinal tract after COVID-19 mRNA vaccination: a report of two cases","volume":"5","author":"Han","year":"2024","journal-title":"Clin Endosc"},{"key":"32","doi-asserted-by":"publisher","first-page":"2006","DOI":"10.3390\/cancers17122006","article-title":"Repeated COVID-19 Vaccination as a Poor Prognostic Factor in Pancreatic Cancer: A Retrospective, Single-Center Cohort Study","volume":"1","author":"Tamai","year":"2025","journal-title":"Cancers (Basel)"},{"key":"33","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1186\/s40792-022-01488-5","article-title":"Axillary lymphangioma that developed following COVID-19 vaccination: a case report","volume":"8","author":"Izumori","year":"2022","journal-title":"Surg Case Rep"},{"key":"34","doi-asserted-by":"publisher","first-page":"627","DOI":"10.3390\/medicina59030627","article-title":"Ph-Positive B-Cell Acute Lymphoblastic Leukemia Occurring after Receipt of Bivalent SARS-CoV-2 mRNA Vaccine Booster: A Case Report","volume":"5","author":"Chang","year":"2023","journal-title":"Medicina (Kaunas)"},{"key":"35","doi-asserted-by":"publisher","first-page":"154310","DOI":"10.1016\/j.prp.2023.154310","article-title":"The case of T-ALL presenting with NK phenotype after COVID-19 vaccination","volume":"24","author":"Murayama","year":"2023","journal-title":"Pathol Res Pract"},{"key":"36","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.jdermsci.2025.09.007","article-title":"A case of metastatic breast carcinoma to the skin expressing SARS-CoV-2 spike protein possibly derived from mRNA vaccine","volume":"12","author":"Sano","year":"2025","journal-title":"J Dermatol Sci"},{"key":"37","doi-asserted-by":"publisher","first-page":"e613","DOI":"10.1111\/jdv.18136","article-title":"Two cases of axillary lymphadenopathy diagnosed as diffuse large B-cell lymphoma developed shortly after BNT162b2 COVID-19 vaccination","volume":"3","author":"Ogido","year":"2022","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"38","doi-asserted-by":"publisher","first-page":"73","DOI":"10.2967\/jnmt.121.263001","article-title":"F-Fluciclovine-Avid Axillary Lymph Nodes After COVID-19 Vaccination on PET\/CT for Suspected Recurrence of Prostate Cancer","volume":"5","author":"McWhorter","year":"2022","journal-title":"J Nucl Med Technol"},{"key":"39","doi-asserted-by":"publisher","first-page":"e32","DOI":"10.1111\/jdv.18615","article-title":"Anaplastic large cell lymphoma at the SARS-CoV2 vaccine injection site","volume":"3","author":"Granados-Pacheco","year":"2023","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"40","doi-asserted-by":"publisher","first-page":"264","DOI":"10.4103\/ijd.ijd_93_23","article-title":"Nodal T-Follicular Helper Cell Lymphoma, Angioimmunoblastic-Type, Diagnosed in a Patient with Psoriasis Following COVID-19 Vaccination under Adalimumab Treatment: A Causal Association?","volume":"6","author":"Tsai","year":"2024","journal-title":"Indian J Dermatol"},{"key":"41","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1007\/s12185-023-03607-w","article-title":"Newly diagnosed extranodal NK\/T-cell lymphoma, nasal type, at the injected left arm after BNT162b2 mRNA COVID-19 vaccination","volume":"11","author":"Sakuraba","year":"2023","journal-title":"Int J Hematol"},{"key":"42","doi-asserted-by":"publisher","first-page":"277","DOI":"10.11406\/rinketsu.64.277","article-title":"[Epstein-Barr virus-associated lymphoproliferative disorders after BNT162b2 mRNA COVID-19 vaccination]","volume":"6","author":"Hara","year":"2023","journal-title":"Rinsho Ketsueki"},{"key":"43","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1111\/bjd.20630","article-title":"Primary cutaneous anaplastic large-cell lymphoma with marked spontaneous regression of organ manifestation after SARS-CoV-2 vaccination","volume":"18","author":"Stranzenbach","year":"2021","journal-title":"Br J Dermatol"},{"key":"44","doi-asserted-by":"publisher","first-page":"798095","DOI":"10.3389\/fmed.2021.798095","article-title":"Rapid Progression of Angioimmunoblastic T Cell Lymphoma Following BNT162b2 mRNA Vaccine Booster Shot: A Case Report","volume":"8","author":"Goldman","year":"2021","journal-title":"Front Med (Lausanne)"},{"key":"45","doi-asserted-by":"publisher","first-page":"2","DOI":"10.55920\/JCRMHS.2023.05.001201","article-title":"Rapid progression of angioimmunoblastic T cell lymphoma after Covid-19 vaccination (Chadox1-S): a case report","volume":"5","author":"Bazyka","year":"2023","journal-title":"J Clin Case Rep Med Image Health Sci"},{"key":"46","doi-asserted-by":"publisher","first-page":"e91","DOI":"10.1111\/jdv.17736","article-title":"Recurrence of cutaneous T-cell lymphoma post viral vector COVID-19 vaccination","volume":"3","author":"Stratigos","year":"2022","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"47","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.jdcr.2022.08.006","article-title":"Subcutaneous panniculitis-like T-cell lymphoma after COVID-19 vaccination","volume":"2","author":"Motaparthi","year":"2022","journal-title":"JAAD Case Rep"},{"key":"48","doi-asserted-by":"publisher","first-page":"e7143","DOI":"10.1002\/ccr3.7143","article-title":"Subcutaneous panniculitis-like T-cell lymphoma post-mRNA-1273 COVID-19 vaccination","volume":"1","author":"Naito","year":"2023","journal-title":"Clin Case Rep"},{"key":"49","doi-asserted-by":"publisher","first-page":"e26070","DOI":"10.7759\/cureus.26070","article-title":"A Case of Chronic Myelomonocytic Leukemia Unmasked After Receiving J&J COVID-19 Vaccine","volume":"1","author":"Shaaban","year":"2022","journal-title":"Cureus"},{"key":"50","doi-asserted-by":"publisher","first-page":"868133","DOI":"10.3389\/fimmu.2022.868133","article-title":"Case Report: Acquired Haemophilia A Following mRNA-1273 Booster Vaccination Against SARS-CoV-2 With Concurrent Diagnosis of Pleomorphic Dermal Sarcoma","volume":"1","author":"Tampe","year":"2022","journal-title":"Front Immunol"},{"key":"51","doi-asserted-by":"publisher","first-page":"3072","DOI":"10.1111\/1759-7714.14179","article-title":"Lung squamous cell carcinoma with hemoptysis after vaccination with tozinameran (BNT162b2, Pfizer-BioNTech)","volume":"1","author":"Chiba","year":"2021","journal-title":"Thorac Cancer"},{"key":"52","doi-asserted-by":"publisher","first-page":"1158124","DOI":"10.3389\/fonc.2023.1158124","article-title":"B-cell lymphoblastic lymphoma following intravenous BNT162b2 mRNA booster in a BALB\/c mouse: A case report","volume":"1","author":"Heidbuchel","year":"2023","journal-title":"Front Oncol"},{"key":"53","doi-asserted-by":"publisher","DOI":"10.22541\/au.172543425.59165134\/v1","article-title":"A systematic review of lymphoma secondary to COVID-19 vaccination","author":"Cheng","year":"2024","journal-title":"Authorea"},{"key":"54","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.clinimag.2022.02.014","article-title":"Metastatic melanoma in the breast and axilla: A case report","volume":"8","author":"Sales","year":"2022","journal-title":"Clin Imaging"},{"key":"55","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1016\/j.radcr.2021.12.002","article-title":"Acute axillary lymphadenopathy detected shortly after COVID-19 vaccination found to be due to newly diagnosed metastatic melanoma","volume":"1","author":"Rowe","year":"2022","journal-title":"Radiol Case Rep"},{"key":"56","doi-asserted-by":"publisher","first-page":"1837","DOI":"10.4103\/ijo.IJO_3040_21","article-title":"Necrosis of uveal melanoma post-COVID-19 vaccination","volume":"7","author":"Sundar","year":"2022","journal-title":"Indian J Ophthalmol"},{"key":"57","doi-asserted-by":"publisher","first-page":"845558","DOI":"10.3389\/fmed.2022.845558","article-title":"Case Report: Malignant Melanoma Associated With COVID-19: A Coincidence or a Clue?","volume":"9","author":"Montesi","year":"2022","journal-title":"Front Med (Lausanne)"},{"key":"58","doi-asserted-by":"publisher","first-page":"e36108","DOI":"10.7759\/cureus.36108","article-title":"A Disguising Fast-Growing Metachronous Melanoma and COVID-19","volume":"1","author":"Simionescu","year":"2023","journal-title":"Cureus"},{"key":"59","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12070-023-03718-0","article-title":"Prevertebral Inflammatory Myofibroblastic Tumor Following COVID Vaccine Booster Dose","volume":"7","author":"de Almeida Teixeira","year":"2023","journal-title":"Indian J Otolaryngol Head Neck Surg"},{"key":"60","doi-asserted-by":"publisher","first-page":"e32400","DOI":"10.7759\/cureus.32400","article-title":"Two Cases of Rare Intratumoral Hemorrhage Following COVID-19 Vaccination","volume":"1","author":"Ichi","year":"2022","journal-title":"Cureus"},{"key":"61","doi-asserted-by":"publisher","first-page":"e289","DOI":"10.1016\/j.chest.2021.04.055","article-title":"A 24-Year-Old Man With Hemoptysis Found to Have a Chest Mass and Contralateral Axillary Lymphadenopathy","volume":"16","author":"Miller","year":"2021","journal-title":"Chest"},{"key":"62","doi-asserted-by":"publisher","first-page":"1269735","DOI":"10.3389\/fonc.2023.1269735","article-title":"A rare adverse effects of COVID-19 vaccine in a patient with a latent tumor: A case report and literature review","volume":"1","author":"Nian","year":"2023","journal-title":"Front Oncol"},{"key":"63","doi-asserted-by":"publisher","first-page":"e76312","DOI":"10.7759\/cureus.76312","article-title":"A Case of Rapid Transformation of a Nail Matrix Nevi to Melanoma After Messenger RNA COVID-19 Vaccine: A Cause or a Coincidence?","volume":"1","author":"Helou","year":"2024","journal-title":"Cureus"},{"key":"64","doi-asserted-by":"publisher","first-page":"1265479","DOI":"10.3389\/fonc.2023.1265479","article-title":"Covid-19, leukemia, and secondary malignancies of the skin - is there a connection: a case report and literature analysis","volume":"1","author":"Berezkin","year":"2023","journal-title":"Front Oncol"},{"key":"65","doi-asserted-by":"publisher","first-page":"160","DOI":"10.3390\/vaccines12020160","article-title":"Right Biceps Pseudo-Tumor from COVID-19 Vaccination","volume":"1","author":"Damron","year":"2024","journal-title":"Vaccines (Basel)"},{"key":"66","doi-asserted-by":"publisher","first-page":"e73121","DOI":"10.7759\/cureus.73121","article-title":"Inflammatory Pseudotumor of the Spleen in a Patient With Psoriatic Arthritis: A Diagnostic Challenge in the COVID-19 Era","volume":"1","author":"Hytiroglou","year":"2024","journal-title":"Cureus"},{"key":"67","first-page":"1","article-title":"Dermatofibrosarcoma Protuberans following COVID-19 and Influenza vaccination: A Case Report","volume":"2","author":"Evangelista","year":"2025","journal-title":"Int J Med Rev Case Rep"},{"key":"68","doi-asserted-by":"publisher","DOI":"10.2106\/JBJS.CC.23.00499","article-title":"Primary Cutaneous Adenoid Cystic Carcinoma in a Rare Location With an Immune Response to a BNT162b2 Vaccine: A Case Report","volume":"1","author":"Tokgozoglu","year":"2024","journal-title":"JBJS Case Connect"},{"key":"69","doi-asserted-by":"publisher","first-page":"e93617","DOI":"10.7759\/cureus.93617","article-title":"Incidental Atrial Myxoma in the Shadow of COVID-19: Coincidence or an Emerging Pattern?","volume":"1","author":"Hassan","year":"2025","journal-title":"Cureus"},{"key":"70","doi-asserted-by":"publisher","first-page":"e64863","DOI":"10.7759\/cureus.64863","article-title":"Recurrent Merkel Cell Carcinoma Following COVID-19 Treatment","volume":"1","author":"Sawada","year":"2024","journal-title":"Cureus"},{"key":"71","doi-asserted-by":"publisher","first-page":"e8278","DOI":"10.1002\/ccr3.8278","article-title":"Metastatic prostatic adenocarcinoma presenting as generalized lymphadenopathy unmasked by a COVID booster vaccine","volume":"1","author":"Brandi","year":"2023","journal-title":"Clin Case Rep"},{"key":"72","doi-asserted-by":"publisher","first-page":"e14822","DOI":"10.1111\/cns.14822","article-title":"Evidences of neurological injury caused by COVID-19 from glioma tissues and glioma organoids","volume":"3","author":"Zhang","year":"2024","journal-title":"CNS Neurosci Ther"},{"key":"73","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1093\/nop\/npae029","article-title":"Accelerated tumor progression after COVID-19 infection in patients with glioblastoma: A retrospective case-control study","volume":"1","author":"Kamiya-Matsuoka","year":"2024","journal-title":"Neurooncol Pract"},{"key":"74","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1038\/s41586-025-09332-0","article-title":"Respiratory viral infections awaken metastatic breast cancer cells in lungs","volume":"64","author":"Zaberezhnyy","year":"2025","journal-title":"Nature"},{"key":"75","doi-asserted-by":"publisher","first-page":"23247096241231645","DOI":"10.1177\/23247096241231645","article-title":"Diagnosis of Angioimmunoblastic T Cell Lymphoma After Receiving First Dose of Pfizer\/BioNTech (BNT162b2) Vaccine: A Case Report","volume":"1","author":"Jamil","year":"2024","journal-title":"J Investig Med High Impact Case Rep"},{"key":"76","doi-asserted-by":"publisher","first-page":"e00005","DOI":"10.14218\/OnA.2025.00005","article-title":"Lymphoid Neoplasms and COVID-19 Vaccination","volume":"3","author":"Madu","year":"2025","journal-title":"Oncol Adv"},{"key":"77","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1080\/25785826.2024.2338594","article-title":"Fatal hemophagocytic lymphohistiocytosis with intravascular large B-cell lymphoma following coronavirus disease 2019 vaccination in a patient with systemic lupus erythematosus: an intertwined case","volume":"4","author":"Masaki","year":"2024","journal-title":"Immunol Med"},{"key":"78","first-page":"1997","article-title":"Diffuse Large B-Cell Lymphoma Developed Shortly After mRNA COVID-19 Vaccination in a Patient with Sickle Cell Disease: A Chicken-and-Egg Problem","volume":"12","author":"Babateen","year":"2025","journal-title":"Bratisl Lek Listy"},{"key":"79","doi-asserted-by":"publisher","first-page":"e451","DOI":"10.1111\/jdv.18806","article-title":"Real-world data on primary cutaneous lymphoproliferative disorders following SARS-CoV-2 vaccination: A multicentre experience from tertiary referral hospitals","volume":"3","author":"Ribero","year":"2023","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"80","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1080\/10428194.2023.2270766","article-title":"Cutaneous lymphoproliferative disorders after COVID-19 vaccination: clinical presentation, histopathology, and outcomes","volume":"6","author":"Geskin","year":"2024","journal-title":"Leuk Lymphoma"},{"key":"81","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.jdcr.2022.12.001","article-title":"Indolent cutaneous lymphoma with gamma\/delta expression after COVID-19 vaccination","volume":"3","author":"Chung","year":"2023","journal-title":"JAAD Case Rep"},{"key":"82","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3897\/pharmacia.71.e135467","article-title":"Lymphoma with skin localization and COVID 19 - a clinical case and review of literature","volume":"7","author":"Becheva","year":"2024","journal-title":"Pharmacia"},{"key":"83","doi-asserted-by":"publisher","DOI":"10.1016\/S0959-8049(22)00617-7","article-title":"SARSCOV-2 vaccine associated with primary cutaneous peripheral T cell lymphoma","author":"Rueda","year":"2022","journal-title":"Eur J Cancer"},{"key":"84","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1007\/s00415-021-10707-2","article-title":"Misinterpretation of glioblastoma as ADEM: potentially harmful consequences of over-diagnosis of COVID-19 vaccine-associated adverse events","volume":"26","author":"Wipfler","year":"2022","journal-title":"J Neurol"},{"key":"85","first-page":"16","article-title":"Non-Hodgkin lymphoma incidence in active component U.S. service members, 2017-2023","volume":"3","author":"Mabila","year":"2025","journal-title":"MSMR"},{"key":"86","doi-asserted-by":"publisher","first-page":"2087","DOI":"10.3390\/life13102087","article-title":"High Risk of Heart Tumors after COVID-19","volume":"1","author":"Shlaykhto","year":"2023","journal-title":"Life (Basel)"},{"key":"87","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1007\/s00432-024-05963-4","article-title":"Transient MRI changes and neurological deterioration in glioblastoma upon SARS-CoV-2 infection","volume":"15","author":"Hoelzel","year":"2024","journal-title":"J Cancer Res Clin Oncol"},{"key":"88","doi-asserted-by":"publisher","first-page":"5064","DOI":"10.1182\/blood-2008-10-184168","article-title":"Cutaneous lymphoma incidence patterns in the United States: a population-based study of 3884 cases","volume":"11","author":"Toro","year":"2009","journal-title":"Blood"},{"key":"89","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1016\/S0140-6736(11)61177-X","article-title":"Burkitt\u2019s lymphoma","volume":"37","author":"Bailey","year":"2012","journal-title":"Lancet"},{"key":"90","doi-asserted-by":"publisher","first-page":"e26319","DOI":"10.7759\/cureus.26319","article-title":"The Rapid Development of Glioblastoma: A Report of Two Cases","volume":"1","author":"Kaprelyan","year":"2022","journal-title":"Cureus"},{"key":"91","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1634\/theoncologist.2008-0075","article-title":"Tumor growth rates derived from data for patients in a clinical trial correlate strongly with patient survival: a novel strategy for evaluation of clinical trial data","volume":"1","author":"Fojo","year":"2008","journal-title":"Oncologist"},{"key":"92","doi-asserted-by":"publisher","first-page":"621329","DOI":"10.3389\/fonc.2020.621329","article-title":"Pre-Treatment Tumor Growth Rate Predicts Clinical Outcomes of Patients With Advanced Non-Small Cell Lung Cancer Undergoing Anti-PD-1\/PD-L1 Therapy","volume":"1","author":"Zhang","year":"2021","journal-title":"Front Oncol"},{"key":"93","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s43057-021-00042-7","article-title":"COVID-19 infection and cardiac angiosarcoma: a dangerous combination-a case report","volume":"2","author":"Ullauri","year":"2021","journal-title":"Cardiothorac Surg"},{"key":"94","doi-asserted-by":"publisher","first-page":"1371581","DOI":"10.3389\/fmicb.2024.1371581","article-title":"Editorial: The association between viral infection and human cancers","volume":"1","author":"Wu","year":"2024","journal-title":"Front Microbiol"},{"key":"95","doi-asserted-by":"publisher","first-page":"106292","DOI":"10.1016\/j.micpath.2023.106292","article-title":"The molecular mechanisms of virus-induced human cancers","volume":"18","author":"Birri","year":"2023","journal-title":"Microb Pathog"},{"key":"96","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.bbadis.2007.12.005","article-title":"Viruses associated with human cancer","volume":"178","author":"Munger","year":"2008","journal-title":"Biochim Biophys Acta"},{"key":"97","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1038\/nrc2961","article-title":"Why do viruses cause cancer? Highlights of the first century of human tumour virology","volume":"1","author":"Chang","year":"2010","journal-title":"Nat Rev Cancer"},{"key":"98","doi-asserted-by":"publisher","first-page":"789427","DOI":"10.3389\/fcell.2021.789427","article-title":"The Critical Contribution of Pseudouridine to mRNA COVID-19 Vaccines","volume":"9","author":"Yu","year":"2021","journal-title":"Front Cell Dev Biol"},{"key":"99","doi-asserted-by":"publisher","first-page":"147","DOI":"10.3390\/vaccines9020147","article-title":"SARS-CoV-2 mRNA Vaccines: Immunological Mechanism and Beyond","volume":"9","author":"Locci","year":"2021","journal-title":"Vaccines (Basel)"},{"key":"100","doi-asserted-by":"publisher","first-page":"e1218","DOI":"10.1002\/prp2.1218","article-title":"Long-lasting, biochemically modified mRNA, and its frameshifted recombinant spike proteins in human tissues and circulation after COVID-19 vaccination","volume":"1","author":"Seneff","year":"2024","journal-title":"Pharmacol Res Perspect"},{"key":"101","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1038\/s41586-023-06800-3","article-title":"N-methylpseudouridylation of mRNA causes +1 ribosomal frameshifting","volume":"62","author":"Lilley","year":"2024","journal-title":"Nature"},{"key":"102","doi-asserted-by":"publisher","first-page":"1920","DOI":"10.1056\/NEJMoa2022483","article-title":"An mRNA Vaccine against SARS-CoV-2 - Preliminary Report","volume":"38","author":"Flach","year":"2020","journal-title":"N Engl J Med"},{"key":"103","doi-asserted-by":"publisher","first-page":"2551517","DOI":"10.1080\/08916934.2025.2551517","article-title":"Quantification of residual plasmid DNA and SV40 promoter-enhancer sequences in Pfizer\/BioNTech and Moderna modRNA COVID-19 vaccines from Ontario, Canada","volume":"5","author":"McKernan","year":"2025","journal-title":"Autoimmunity"},{"key":"104","unstructured":"Raoult. Confirmation of the presence of vaccine DNA in the Pfizer anti-COVID-19 vaccine. 2024. https:\/\/hal.science\/hal-04778576v1."},{"key":"105","doi-asserted-by":"publisher","first-page":"127022","DOI":"10.1016\/j.vaccine.2025.127022","article-title":"Quantification of objective concentrations of DNA impurities in mRNA vaccines","volume":"5","author":"Marschalek","year":"2025","journal-title":"Vaccine"},{"key":"106","unstructured":"Science, Public Health Policy, and the Law Volume: v5.2019-2024. December 2024. https:\/\/www.researchgate.net\/publication\/386414408_BioNTech_RNA-Based_COVID-19_Injections_Contain_Large_Amounts_Of_Residual_DNA_Including_An_SV40_PromoterEnhancer_Sequence."},{"key":"107","doi-asserted-by":"publisher","first-page":"41","DOI":"10.3390\/mps7030041","article-title":"Methodological Considerations Regarding the Quantification of DNA Impurities in the COVID-19 mRNA Vaccine Comirnaty","volume":"7","author":"Kirchner","year":"2024","journal-title":"Methods Protoc"},{"key":"108","article-title":"A rapid detection method of replication-competent plasmid DNA from COVID-19 mRNA vaccines for quality control","volume":"8","author":"Kim","year":"2024","journal-title":"JHSS"},{"key":"109","doi-asserted-by":"publisher","first-page":"2494934","DOI":"10.1080\/21645515.2025.2494934","article-title":"Detection of S1 spike protein in CD16+ monocytes up to 245 days in SARS-CoV-2-negative post-COVID-19 vaccine syndrome (PCVS) individuals","volume":"2","author":"Mora-Rodr\u00edguez","year":"2025","journal-title":"Hum Vaccin Immunother"},{"key":"110","article-title":"Immunological and Antigenic Signatures Associated with Chronic Illnesses after COVID-19 Vaccination","author":"Bhattacharjee","year":"2025","journal-title":"medRxiv"},{"key":"111","first-page":"e43478","article-title":"Breaking the silence: Recognizing post-vaccination syndrome","volume":"1","author":"Varon","year":"2025","journal-title":"Heliyon"},{"key":"112","doi-asserted-by":"publisher","first-page":"10514","DOI":"10.3390\/ijms241310514","article-title":"mRNA: Vaccine or Gene Therapy? The Safety Regulatory Issues","volume":"2","author":"Banoun","year":"2023","journal-title":"Int J Mol Sci"},{"key":"113","unstructured":"https:\/\/www.fda.gov\/vaccines-blood-biologics\/cellular-gene-therapy-products\/what-gene-therapy."},{"key":"114","unstructured":"https:\/\/www.europarl.europa.eu\/doceo\/document\/E-9-2024-000355_EN.html."},{"key":"115","doi-asserted-by":"publisher","first-page":"1616106","DOI":"10.3389\/fimmu.2025.1616106","article-title":"Soluble SARS-CoV-2 Spike glycoprotein: considering some potential pathogenic effects","volume":"1","author":"Maggi","year":"2025","journal-title":"Front Immunol"},{"key":"116","doi-asserted-by":"publisher","DOI":"10.1101\/2022.06.14.22276401","article-title":"Persistent circulating SARS-CoV-2 spike is associated with post-acute COVID-19 sequelae","author":"Walt","year":"2022","journal-title":"medrxiv"},{"key":"117","doi-asserted-by":"publisher","first-page":"736","DOI":"10.3390\/vaccines12070736","article-title":"Long-Lasting Enhanced Cytokine Responses Following SARS-CoV-2 BNT162b2 mRNA Vaccination","volume":"1","author":"Joosten","year":"2024","journal-title":"Vaccines (Basel)"},{"key":"118","doi-asserted-by":"publisher","first-page":"e35951","DOI":"10.7759\/cureus.35951","article-title":"Inflammatory Arthritis Associated with COVID-19 Vaccination","volume":"1","author":"Jude","year":"2023","journal-title":"Cureus"},{"key":"119","doi-asserted-by":"publisher","first-page":"3838","DOI":"10.1093\/rheumatology\/kead144","article-title":"Flares in autoimmune rheumatic diseases in the post-COVID-19 vaccination period-a cross-sequential study based on COVAD surveys","volume":"6","author":"Joshi","year":"2023","journal-title":"Rheumatology (Oxford)"},{"key":"120","doi-asserted-by":"publisher","first-page":"6835","DOI":"10.1038\/s41598-023-33862-0","article-title":"High spontaneous integration rates of end-modified linear DNAs upon mammalian cell transfection","volume":"1","author":"Way","year":"2023","journal-title":"Sci Rep"},{"key":"121","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1038\/s41590-022-01160-y","article-title":"IL-1 and IL-1ra are key regulators of the inflammatory response to RNA vaccines","volume":"2","author":"Haley","year":"2022","journal-title":"Nat Immunol"},{"key":"122","doi-asserted-by":"publisher","first-page":"1292568","DOI":"10.3389\/fimmu.2023.1292568","article-title":"Rapid transient and longer-lasting innate cytokine changes associated with adaptive immunity after repeated SARS-CoV-2 BNT162b2 mRNA vaccinations","volume":"1","author":"Felber","year":"2023","journal-title":"Front Immunol"},{"key":"123","doi-asserted-by":"publisher","first-page":"7226","DOI":"10.1038\/s41467-024-51411-9","article-title":"Innate immune responses against mRNA vaccine promote cellular immunity through IFN-\u03b2 at the injection site","volume":"1","author":"Kim","year":"2024","journal-title":"Nat Commun"},{"key":"124","doi-asserted-by":"publisher","first-page":"2291","DOI":"10.1097\/MS9.0000000000000679","article-title":"IL1\u03b2, IL-6, and TNF-\u03b1 cytokines cooperate to modulate a complicated medical condition among COVID-19 patients: case-control study","volume":"8","author":"Jalal","year":"2023","journal-title":"Ann Med Surg (Lond)"},{"key":"125","doi-asserted-by":"publisher","first-page":"24842","DOI":"10.1021\/acsnano.4c05088","article-title":"Lipid Nanoparticles Elicit Reactogenicity and Sickness Behavior in Mice Via Toll-Like Receptor 4 and Myeloid Differentiation Protein 88 Axis","volume":"1","author":"Goo","year":"2024","journal-title":"ACS Nano"},{"key":"126","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1038\/s41541-023-00751-6","article-title":"Effect of mRNA-LNP components of two globally-marketed COVID-19 vaccines on efficacy and stability","volume":"8","author":"Choe","year":"2023","journal-title":"NPJ Vaccines"},{"key":"127","doi-asserted-by":"publisher","first-page":"2872","DOI":"10.1016\/j.ymthe.2024.12.019","article-title":"mRNA-LNPs induce immune activation and cytokine release in human whole blood assays across diverse health conditions","volume":"3","author":"Thorn","year":"2025","journal-title":"Mol Ther"},{"key":"128","doi-asserted-by":"publisher","first-page":"1591119","DOI":"10.3389\/fmedt.2025.1591119","article-title":"Enhancing nucleic acid delivery by the integration of artificial intelligence into lipid nanoparticle formulation","volume":"7","author":"Hwa","year":"2025","journal-title":"Front Med Technol"},{"key":"129","doi-asserted-by":"publisher","first-page":"59","DOI":"10.3390\/biomedicines12010059","article-title":"Biodistribution of RNA Vaccines and of Their Products: Evidence from Human and Animal Studies","volume":"1","author":"Reshetnikov","year":"2023","journal-title":"Biomedicines"},{"key":"130","doi-asserted-by":"publisher","first-page":"149185","DOI":"10.1155\/2014\/149185","article-title":"Chronic inflammation and cytokines in the tumor microenvironment","volume":"201","author":"Hermoso","year":"2014","journal-title":"J Immunol Res"},{"key":"131","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.semcancer.2021.03.023","article-title":"Multifaceted functions of chronic inflammation in regulating tumor dormancy and relapse","volume":"7","author":"Manjili","year":"2022","journal-title":"Semin Cancer Biol"},{"key":"132","doi-asserted-by":"publisher","first-page":"eaao4227","DOI":"10.1126\/science.aao4227","article-title":"Neutrophil extracellular traps produced during inflammation awaken dormant cancer cells in mice","volume":"36","author":"Bautista","year":"2018","journal-title":"Science"},{"key":"133","doi-asserted-by":"publisher","first-page":"eabb5817","DOI":"10.1126\/scitranslmed.abb5817","article-title":"Reactivation of dormant tumor cells by modified lipids derived from stress-activated neutrophils","volume":"1","author":"Vogl","year":"2020","journal-title":"Sci Transl Med"},{"key":"134","doi-asserted-by":"publisher","first-page":"1436581","DOI":"10.3389\/fimmu.2024.1436581","article-title":"Immune-Mediated Inflammatory Diseases and Cancer - a dangerous liaison","volume":"1","author":"Ardizzone","year":"2024","journal-title":"Front Immunol"},{"key":"135","doi-asserted-by":"publisher","first-page":"1289313","DOI":"10.3389\/fimmu.2023.1289313","article-title":"Mechanisms of T cell evasion by Epstein-Barr virus and implications for tumor survival","volume":"1","author":"Smith","year":"2023","journal-title":"Front Immunol"},{"key":"136","doi-asserted-by":"publisher","first-page":"613","DOI":"10.3389\/fmicb.2017.00613","article-title":"Reactivation and Lytic Replication of Kaposi\u2019s Sarcoma-Associated Herpesvirus: An Update","volume":"8","author":"Yuan","year":"2017","journal-title":"Front Microbiol"},{"key":"137","doi-asserted-by":"publisher","first-page":"451","DOI":"10.2217\/fvl.11.21","article-title":"Virus reactivation: a panoramic view in human infections","volume":"6","author":"Akula","year":"2011","journal-title":"Future Virol"},{"key":"138","first-page":"2232","article-title":"Hyperprogression after immunotherapy: A comprehensive review","volume":"2","author":"Ozdogan","year":"2019","journal-title":"J BUON"},{"key":"139","doi-asserted-by":"publisher","first-page":"678409","DOI":"10.3389\/fphar.2021.678409","article-title":"Hyperprogressive Disease in Cancers Treated With Immune Checkpoint Inhibitors","volume":"1","author":"Tu","year":"2021","journal-title":"Front Pharmacol"},{"key":"140","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1634\/theoncologist.2019-0636","article-title":"Hyperprogression and Immune Checkpoint Inhibitors: Hype or Progress?","volume":"2","author":"Kurzrock","year":"2020","journal-title":"Oncologist"},{"key":"141","doi-asserted-by":"publisher","first-page":"10514","DOI":"10.1128\/JVI.79.16.10514-10527.2005","article-title":"Intrinsic functional dysregulation of CD4 T cells occurs rapidly following persistent viral infection","volume":"7","author":"McGavern","year":"2005","journal-title":"J Virol"},{"key":"142","doi-asserted-by":"publisher","first-page":"3578","DOI":"10.1128\/jvi.78.7.3578-3600.2004","article-title":"Differential tissue-specific regulation of antiviral CD8+ T-cell immune responses during chronic viral infection","volume":"7","author":"Moskophidis","year":"2004","journal-title":"J Virol"},{"key":"143","doi-asserted-by":"publisher","first-page":"755579","DOI":"10.3389\/fimmu.2021.755579","article-title":"Severe Adaptive Immune Suppression May Be Why Patients With Severe COVID-19 Cannot Be Discharged From the ICU Even After Negative Viral Tests","volume":"1","author":"Zhang","year":"2021","journal-title":"Front Immunol"},{"key":"144","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1038\/nri3552","article-title":"Sepsis-induced immunosuppression: from cellular dysfunctions to immunotherapy","volume":"1","author":"Payen","year":"2013","journal-title":"Nat Rev Immunol"},{"key":"145","doi-asserted-by":"publisher","first-page":"eade2798","DOI":"10.1126\/sciimmunol.ade2798","article-title":"Class switch toward noninflammatory, spike-specific IgG4 antibodies after repeated SARS-CoV-2 mRNA vaccination","volume":"8","author":"Falcone","year":"2023","journal-title":"Sci Immunol"},{"key":"146","doi-asserted-by":"publisher","first-page":"1530301","DOI":"10.3389\/fimmu.2025.1530301","article-title":"Recent advances in regulatory immune cells: exploring the world beyond Tregs","volume":"1","author":"Zhao","year":"2025","journal-title":"Front Immunol"},{"key":"147","doi-asserted-by":"publisher","first-page":"2162","DOI":"10.1158\/0008-5472.CAN-11-3687","article-title":"T-regulatory cells: key players in tumor immune escape and angiogenesis","volume":"7","author":"Coukos","year":"2012","journal-title":"Cancer Res"},{"key":"148","doi-asserted-by":"publisher","first-page":"e25961","DOI":"10.4161\/onci.25961","article-title":"Immune modulation of the tumor microenvironment for enhancing cancer immunotherapy","volume":"2","author":"Kershaw","year":"2013","journal-title":"Oncoimmunology"},{"key":"149","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1186\/s13046-025-03377-9","article-title":"Tumor-associated macrophages remodel the suppressive tumor immune microenvironment and targeted therapy for immunotherapy","volume":"4","author":"Fu","year":"2025","journal-title":"J Exp Clin Cancer Res"},{"key":"150","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/s00221-021-06244-z","article-title":"Neurotropism of SARS-CoV-2 and neurological diseases of the central nervous system in COVID-19 patients","volume":"24","author":"Veleri","year":"2022","journal-title":"Exp Brain Res"},{"key":"151","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.bbi.2023.01.010","article-title":"Blood-brain barrier penetration of non-replicating SARS-CoV-2 and S1 variants of concern induce neuroinflammation which is accentuated in a mouse model of Alzheimer\u2019s disease","volume":"10","author":"Kovac","year":"2023","journal-title":"Brain Behav Immun"},{"key":"152","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1161\/CIRCRESAHA.121.318902","article-title":"SARS-CoV-2 Spike Protein Impairs Endothelial Function via Downregulation of ACE 2","volume":"12","author":"Lei","year":"2021","journal-title":"Circ Res"},{"key":"153","doi-asserted-by":"publisher","first-page":"827146","DOI":"10.3389\/fimmu.2022.827146","article-title":"SARS-CoV-2 Spike Protein 1 Activates Microvascular Endothelial Cells and Complement System Leading to Platelet Aggregation","volume":"1","author":"Remuzzi","year":"2022","journal-title":"Front Immunol"},{"key":"154","doi-asserted-by":"publisher","first-page":"11392","DOI":"10.1038\/s41598-023-38382-5","article-title":"SARS-CoV-2 spike protein induces lung endothelial cell dysfunction and thrombo-inflammation depending on the C3a\/C3a receptor signalling","volume":"1","author":"Remuzzi","year":"2023","journal-title":"Sci Rep"},{"key":"155","doi-asserted-by":"publisher","first-page":"101695","DOI":"10.1016\/j.jbc.2022.101695","article-title":"The spike protein of SARS-CoV-2 induces endothelial inflammation through integrin \u03b15\u03b21 and NF-\u03baB signaling","volume":"29","author":"Clapp","year":"2022","journal-title":"J Biol Chem"},{"key":"156","doi-asserted-by":"publisher","first-page":"11179","DOI":"10.1038\/s41598-024-61906-6","article-title":"Mechanistic insights into SARS-CoV-2 spike protein induction of the chemokine CXCL10","volume":"1","author":"Goetz","year":"2024","journal-title":"Sci Rep"},{"key":"157","doi-asserted-by":"publisher","first-page":"2531","DOI":"10.1007\/s10753-024-02208-x","article-title":"Sustained Vascular Inflammatory Effects of SARS-CoV-2 Spike Protein on Human Endothelial Cells","volume":"4","author":"Rieben","year":"2025","journal-title":"Inflammation"},{"key":"158","doi-asserted-by":"publisher","first-page":"e1012291","DOI":"10.1371\/journal.ppat.1012291","article-title":"SARS-CoV-2 spike-induced syncytia are senescent and contribute to exacerbated heart failure","volume":"2","author":"Hou","year":"2024","journal-title":"PLoS Pathog"},{"key":"159","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1186\/s12964-024-01818-0","article-title":"Oncogenic potential of SARS-CoV-2-targeting hallmarks of cancer pathways","volume":"2","author":"Singh","year":"2024","journal-title":"Cell Commun Signal"},{"key":"160","doi-asserted-by":"publisher","first-page":"001918","DOI":"10.1099\/jgv.0.001918","article-title":"SARS-CoV-2 and the DNA damage response","volume":"10","author":"Grand","year":"2023","journal-title":"J Gen Virol"},{"key":"161","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1002\/cac2.12485","article-title":"The SARS-CoV-2 spike protein induces lung cancer migration and invasion in a TLR2-dependent manner","volume":"4","author":"Lee","year":"2024","journal-title":"Cancer Commun (Lond)"},{"key":"162","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1097\/j.pain.0000000000002097","article-title":"SARS-CoV-2 spike protein co-opts VEGF-A\/neuropilin-1 receptor signaling to induce analgesia","volume":"16","author":"Khanna","year":"2021","journal-title":"Pain"},{"key":"163","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.3390\/v15051045","article-title":"Molecular Mimicry of the Viral Spike in the SARS-CoV-2 Vaccine Possibly Triggers Transient Dysregulation of ACE2, Leading to Vascular and Coagulation Dysfunction Similar to SARS-CoV-2 Infection","volume":"1","author":"Camoin-Jau","year":"2023","journal-title":"Viruses"},{"key":"164","doi-asserted-by":"publisher","first-page":"275","DOI":"10.18632\/oncotarget.28582","article-title":"Transfected SARS-CoV-2 spike DNA for mammalian cell expression inhibits p53 activation of p21(WAF1), TRAIL Death Receptor DR5 and MDM2 proteins in cancer cells and increases cancer cell viability after chemotherapy exposure","volume":"1","author":"El-Deiry","year":"2024","journal-title":"Oncotarget"},{"key":"165","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1038\/s41556-023-01096-x","article-title":"SARS-CoV-2 infection induces DNA damage, through CHK1 degradation and impaired 53BP1 recruitment, and cellular senescence","volume":"2","author":"Iacomino","year":"2023","journal-title":"Nat Cell Biol"},{"key":"166","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1038\/s43587-022-00170-7","article-title":"SARS-CoV-2 infection triggers paracrine senescence and leads to a sustained senescence-associated inflammatory response","volume":"2","author":"Okumura","year":"2022","journal-title":"Nat Aging"},{"key":"167","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1093\/cid\/ciab465","article-title":"Circulating Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Vaccine Antigen Detected in the Plasma of mRNA-1273 Vaccine Recipients","volume":"7","author":"Walt","year":"2022","journal-title":"Clin Infect Dis"},{"key":"168","doi-asserted-by":"publisher","first-page":"1538","DOI":"10.3390\/biomedicines10071538","article-title":"Vaccine mRNA Can Be Detected in Blood at 15 Days Post-Vaccination","volume":"1","author":"Gherghiceanu","year":"2022","journal-title":"Biomedicines"},{"key":"169","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1002\/cia2.12278","article-title":"Persistent varicella zoster virus infection following mRNA COVID-19 vaccination was associated with the presence of encoded spike protein in the lesion","volume":"6","author":"Sano","year":"2022","journal-title":"J Allergy Clin Immunol"},{"key":"170","doi-asserted-by":"publisher","first-page":"e2300048","DOI":"10.1002\/prca.202300048","article-title":"Detection of recombinant Spike protein in the blood of individuals vaccinated against SARS-CoV-2: Possible molecular mechanisms","volume":"1","author":"Piscopo","year":"2023","journal-title":"Proteomics Clin Appl"},{"key":"171","doi-asserted-by":"publisher","first-page":"315","DOI":"10.3390\/vaccines13030315","article-title":"Stabilizing Prefusion SARS-CoV-2 Spike by Destabilizing the Postfusion Conformation","volume":"1","author":"Varadarajan","year":"2025","journal-title":"Vaccines (Basel)"},{"key":"172","doi-asserted-by":"publisher","first-page":"2112","DOI":"10.1016\/j.chom.2024.11.007","article-title":"Persistence of spike protein at the skull-meninges-brain axis may contribute to the neurological sequelae of COVID-19","volume":"3","author":"Steinke","year":"2024","journal-title":"Cell Host Microbe"},{"key":"173","unstructured":"Report of the WHO Study Group on Cell Substrates for Production of Biologicals. World Health Organization. 2024."},{"key":"174","doi-asserted-by":"publisher","first-page":"1426129","DOI":"10.3389\/fmolb.2024.1426129","article-title":"Understanding the impact oftranscription byproducts and contaminants","volume":"1","author":"Vlatkovic","year":"2024","journal-title":"Front Mol Biosci"},{"key":"175","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/1472-6750-10-9","article-title":"Comparative transfection of DNA into primary and transformed mammalian cells from different lineages","volume":"1","author":"Gruenert","year":"2010","journal-title":"BMC Biotechnol"},{"key":"176","doi-asserted-by":"publisher","DOI":"10.1101\/2024.06.11.598533","article-title":"Enabling non-viral DNA delivery using lipid nanoparticles co-loaded with endogenous anti-inflammatory lipids","author":"Katzen","year":"2024","journal-title":"bioRxiv"},{"key":"177","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1126\/science.1690918","article-title":"Direct gene transfer into mouse muscle","volume":"24","author":"Felgner","year":"1990","journal-title":"Science"},{"key":"178","first-page":"71","article-title":"Direct gene transfer and expression into rat heart","volume":"3","author":"Wolff","year":"1991","journal-title":"New Biol"},{"key":"179","first-page":"703","article-title":"Gene transfer and expression in rat cardiac transplants","volume":"5","author":"Knechtle","year":"1992","journal-title":"Transplantation"},{"key":"180","unstructured":"(Comirnaty), I. P.-. Residual DNA Characterization Report. https:\/\/www.ghr.agency\/wp-content\/uploads\/2025\/08\/comirnaty-residual-dna-characterization-report_en.pdf."},{"key":"181","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1006\/mthe.2002.0657","article-title":"Durability of transgene expression and vector integration: recombinant SV40-derived gene therapy vectors","volume":"6","author":"Chowdhury","year":"2002","journal-title":"Mol Ther"},{"key":"182","doi-asserted-by":"publisher","first-page":"103479","DOI":"10.1016\/j.isci.2021.103479","article-title":"The mRNA-LNP platform\u2019s lipid nanoparticle component used in preclinical vaccine studies is highly inflammatory","volume":"2","author":"Igy\u00e1rt\u00f3","year":"2021","journal-title":"iScience"},{"key":"183","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1038\/s41576-019-0151-1","article-title":"DNA sensing by the cGAS-STING pathway in health and disease","volume":"2","author":"Fitzgerald","year":"2019","journal-title":"Nat Rev Genet"},{"key":"184","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1158\/2159-8290.CD-19-0761","article-title":"The Cytosolic DNA-Sensing cGAS-STING Pathway in Cancer","volume":"1","author":"Bakhoum","year":"2020","journal-title":"Cancer Discov"},{"key":"185","doi-asserted-by":"publisher","first-page":"155","DOI":"10.5731\/pdajpst.2013.00910","article-title":"Establishing acceptable limits of residual DNA","volume":"6","author":"Yang","year":"2013","journal-title":"PDA J Pharm Sci Technol"},{"key":"186","doi-asserted-by":"crossref","first-page":"2630","DOI":"10.1200\/JCO.2022.40.16_suppl.2630","article-title":"A pancancer analysis of impact of MDM2\/MDM4 on immune checkpoint blockade ICB","volume":"4","author":"El-Deiry","year":"2022","journal-title":"J Clin Oncol"},{"key":"187","first-page":"2102","article-title":"amplification anddeletion in metastatic melanoma and glioblastoma multiforme may have implications for targeted therapeutics and immunotherapy","volume":"1","author":"El-Deiry","year":"2022","journal-title":"Am J Cancer Res"},{"key":"188","doi-asserted-by":"publisher","first-page":"2080","DOI":"10.1200\/JCO.2024.42.16_suppl.2080","article-title":"Therapeutic insights for the aggressive subset of high-grade gliomas (HGG) driven by chromosome 1q32 MDM4-containing amplicon and unmethylated MGMT","volume":"4","author":"Kurzrock","year":"2024","journal-title":"J Clin Oncol"},{"key":"189","doi-asserted-by":"publisher","first-page":"e64958","DOI":"10.7554\/eLife.64958","article-title":"Cytokine ranking via mutual information algorithm correlates cytokine profiles with presenting disease severity in patients infected with SARS-CoV-2","volume":"1","author":"El-Deiry","year":"2021","journal-title":"Elife"},{"key":"190","doi-asserted-by":"publisher","first-page":"eadv4214","DOI":"10.1126\/scitranslmed.adv4214","article-title":"Longitudinal antibody titers measured after COVID-19 mRNA vaccination can identify individuals at risk for subsequent infection","volume":"1","author":"Kawashima","year":"2025","journal-title":"Sci Transl Med"},{"key":"191","doi-asserted-by":"publisher","first-page":"4201","DOI":"10.18632\/oncotarget.27799","article-title":"MEK inhibitors reduce cellular expression of ACE2, pERK, pRb while stimulating NK-mediated cytotoxicity and attenuating inflammatory cytokines relevant to SARS-CoV-2 infection","volume":"1","author":"S Campbell","year":"2020","journal-title":"Oncotarget"},{"key":"192","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1016\/j.neo.2020.09.005","article-title":"ONC201 and imipridones: Anti-cancer compounds with clinical efficacy","volume":"2","author":"Chang","year":"2020","journal-title":"Neoplasia"},{"key":"193","doi-asserted-by":"publisher","first-page":"e173649","DOI":"10.1172\/JCI173649","article-title":"TRAIL agonists rescue mice from radiation-induced lung, skin, or esophageal injury","volume":"13","author":"Koffer","year":"2025","journal-title":"J Clin Invest"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.28824","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T15:00:31Z","timestamp":1767711631000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.28824"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,3]]},"references-count":193,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1,3]]}},"alternative-id":["28824"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.28824","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,3]]}}}